D-Index & Metrics Best Publications
Joellen M. Schildkraut

Joellen M. Schildkraut

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 86 Citations 23,969 340 World Ranking 7233 National Ranking 3973

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

His primary scientific interests are in Ovarian cancer, Cancer, Internal medicine, Odds ratio and Risk factor. His Ovarian cancer research is multidisciplinary, incorporating perspectives in Cancer research, Gynecology, Serous fluid and Genome-wide association study. Joellen M. Schildkraut interconnects Hysterectomy and Disease in the investigation of issues within Gynecology.

His work carried out in the field of Cancer brings together such families of science as Obstetrics, Epidemiology, Case-control study and Ovary. Joellen M. Schildkraut has included themes like Differentially methylated regions, Endocrinology, Andrology and Oncology in his Internal medicine study. His studies deal with areas such as Relative risk, Confidence interval, Randomized controlled trial, Family medicine and Prospective cohort study as well as Risk factor.

His most cited work include:

  • Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality (965 citations)
  • Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (951 citations)
  • The genetic attributable risk of breast and ovarian cancer (632 citations)

What are the main themes of his work throughout his whole career to date?

Joellen M. Schildkraut focuses on Internal medicine, Ovarian cancer, Oncology, Cancer and Odds ratio. In his study, which falls under the umbrella issue of Internal medicine, Epigenetics, DNA methylation and Genomic imprinting is strongly linked to Endocrinology. The study incorporates disciplines such as Serous fluid, Carcinoma, Gynecology and Single-nucleotide polymorphism, Genotype in addition to Ovarian cancer.

His biological study deals with issues like Proportional hazards model, which deal with fields such as Hazard ratio. His research on Cancer often connects related areas such as Candidate gene. The Odds ratio study combines topics in areas such as Logistic regression, Lower risk, Confidence interval, Epidemiology of cancer and Confounding.

He most often published in these fields:

  • Internal medicine (56.39%)
  • Ovarian cancer (56.39%)
  • Oncology (45.70%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (56.39%)
  • Oncology (45.70%)
  • Ovarian cancer (56.39%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Oncology, Ovarian cancer, Odds ratio and Genome-wide association study. Joellen M. Schildkraut combines subjects such as Body mass index, Case-control study, Glioma and Single-nucleotide polymorphism, Genotype with his study of Oncology. His Ovarian cancer study combines topics in areas such as Epidemiology, Incidence, Breast cancer, Epidemiology of cancer and Hazard ratio.

His Odds ratio research also works with subjects such as

  • Logistic regression which connect with Gynecology,
  • Confidence interval that intertwine with fields like Population study,
  • Obstetrics which is related to area like Pregnancy and Endometriosis,
  • Family history which intersects with area such as Risk factor. His Genome-wide association study study incorporates themes from Cancer research, Estrogen receptor, Genetic association and Germline. He interconnects Relative risk and Quality of life in the investigation of issues within Cancer.

Between 2017 and 2021, his most popular works were:

  • Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage. (90 citations)
  • Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study (29 citations)
  • Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21 (26 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

His primary areas of study are Internal medicine, Oncology, Genome-wide association study, Serous fluid and Cancer. His Internal medicine research includes elements of Mendelian Randomization Analysis and Glioma. His biological study spans a wide range of topics, including Mendelian randomization and Prostate.

His Genome-wide association study research incorporates elements of Methylation, DNA methylation, Genetic model, Case-control study and Genetic association. His Serous fluid research includes themes of Ovarian carcinoma, Ovarian tumor, Ovarian cancer and Adenocarcinoma. His specific area of interest is Cancer, where he studies Breast cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

Susan M. Domchek;Tara M. Friebel;Christian F. Singer;D. Gareth Evans.
JAMA (2010)

1320 Citations

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)

951 Citations

The genetic attributable risk of breast and ovarian cancer

Elizabeth B. Claus;Joellen M. Schildkraut;W. Douglas Thompson;Neil J. Risch.
Cancer (1996)

949 Citations

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.

Celeste Leigh Pearce;Claire Templeman;Mary Anne Rossing;Alice Lee.
Lancet Oncology (2012)

822 Citations

Epidemiology of intracranial meningioma.

Elizabeth B Claus;Elizabeth B Claus;Melissa L Bondy;Joellen M Schildkraut;Joseph L Wiemels.
Neurosurgery (2005)

577 Citations

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)

547 Citations

Probability of Carrying a Mutation of Breast-Ovarian Cancer Gene BRCA1 Based on Family History

Donald A. Berry;Giovanni Parmigiani;Juana Sanchez;Joellen Schildkraut.
Journal of the National Cancer Institute (1997)

411 Citations

Epithelial ovarian cancer risk among women with polycystic ovary syndrome

Joellen M. Schildkraut;Pamela J. Schwingl;Eugenia Bastos;Allison Evanoff.
Obstetrics & Gynecology (1996)

392 Citations

Characterization of BRCA1 and BRCA2 Mutations in a Large United States Sample

Sining Chen;Edwin S. Iversen;Tara Friebel;Dianne Finkelstein.
Journal of Clinical Oncology (2006)

380 Citations

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

Paul D.P. Pharoah;Ya Yu Tsai;Susan J. Ramus;Catherine M. Phelan.
Nature Genetics (2013)

355 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Joellen M. Schildkraut

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 175

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 134

Douglas F. Easton

Douglas F. Easton

University of Cambridge

Publications: 130

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 129

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 115

Georgia Chenevix-Trench

Georgia Chenevix-Trench

QIMR Berghofer Medical Research Institute

Publications: 105

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 98

Irene L. Andrulis

Irene L. Andrulis

University of Toronto

Publications: 96

Fergus J. Couch

Fergus J. Couch

Mayo Clinic

Publications: 95

Shelley S. Tworoger

Shelley S. Tworoger

Harvard University

Publications: 95

Hiltrud Brauch

Hiltrud Brauch

German Cancer Research Center

Publications: 94

Melissa C. Southey

Melissa C. Southey

Cancer Council Victoria

Publications: 92

Susan M. Domchek

Susan M. Domchek

University of Pennsylvania

Publications: 91

Kenneth Offit

Kenneth Offit

Memorial Sloan Kettering Cancer Center

Publications: 91

Esther M. John

Esther M. John

Stanford University

Publications: 89

Stig E. Bojesen

Stig E. Bojesen

University of Copenhagen

Publications: 81

Trending Scientists

Chang-Jin Kim

Chang-Jin Kim

University of Washington

Meng-Fan Chang

Meng-Fan Chang

National Tsing Hua University

Emmanuel Lacôte

Emmanuel Lacôte

University of Lyon System

Dwight S. Seferos

Dwight S. Seferos

University of Toronto

Wolfram Koch

Wolfram Koch

German Chemical Society (Gesellschaft Deutscher Chemiker)

Yoshinori Ando

Yoshinori Ando

Meijo University

William Block

William Block

British Antarctic Survey

Anthony L. DeFranco

Anthony L. DeFranco

University of California, San Francisco

John M. Klinck

John M. Klinck

Old Dominion University

Daniel H. Weissman

Daniel H. Weissman

University of Michigan–Ann Arbor

A. J. Van Opstal

A. J. Van Opstal

Radboud University Nijmegen

Gordon L. Shulman

Gordon L. Shulman

Washington University in St. Louis

Christopher S. Colwell

Christopher S. Colwell

University of California, Los Angeles

Maria E. Arcila

Maria E. Arcila

Memorial Sloan Kettering Cancer Center

Mikkel Østergaard

Mikkel Østergaard

University of Copenhagen

Anette-G. Ziegler

Anette-G. Ziegler

Technical University of Munich

Something went wrong. Please try again later.